Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2025-12-24 @ 5:36 PM
NCT ID:
NCT00532168
Eligibility Criteria:
Inclusion Criteria:
* Chronic HIV-1 infection
* Age 18 or more
* Antiretroviral-naive
* Baseline CD4+ count \<100 cels/mcL.
* No mutations of drug resistance at baseline (M184V/I, K65R, resistance to efavirenz or 2 or more PRAMs (L33I/F/V, V82A/F/L/T, I84V, L90M)
* Written informed consent
Exclusion Criteria:
* Hypersensibility to study drugs.
* Pregnancy or breastfeeding
* Active OI requiring admission
* Active lymphoma or malignancy (Kaposi sarcoma included)
* Cl creatinine below 30 ml/min.
* Liver failure
* Treatment with nephrotoxic drugs, immunomodulators, interleukine-2, systemic steroids or investigational products.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00532168
Study Brief:
Protocol Section:
NCT00532168